The stock of Omega Diagnostics Group Plc (LON:ODX) is a huge mover today! The stock increased 1.45% or GBX 0.25 on November 23, hitting GBX 17.5. About 275,511 shares traded hands or 362.52% up from the average. Omega Diagnostics Group Plc (LON:ODX) has risen 6.98% since April 25, 2016 and is uptrending. It has outperformed by 1.65% the S&P500.
The move comes after 9 months negative chart setup for the GBX 19.31M company. It was reported on Nov, 23 by Barchart.com. We have GBX 16.98 PT which if reached, will make LON:ODX worth GBX 579,300 less.
Another recent and important Omega Diagnostics Group Plc (LON:ODX) news was published by Fool.Co.Uk which published an article titled: “Should I Sell Shire plc & Buy Omega Diagnostics Group plc Right Now?” on July 07, 2015.
Omega Diagnostics Group PLC is a medical diagnostics company. The company has a market cap of 19.31 million GBP. The Company’s divisions are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. It has a 29.81 P/E ratio. The Company’s product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.